Blog
RSS FeedPosted by Michael Wonder on 04 Sep 2023
Working with Te Whatu Ora to enable better access to vaccines
4 September 2023 - This year, many New Zealanders received their vaccinations at pharmacies close to their homes or workplaces. ...
Posted by Michael Wonder on 02 Sep 2023
Additional COVID-19 vaccine dose recommended for adults 75 years and over
1 September 2023 - The Australian Government has accepted advice from the Australian Technical Advisory Group on Immunisation (ATAGI) that all ...
Posted by Michael Wonder on 22 Aug 2023
CDC, pharmacies try to speed up Covid vaccine program for the uninsured
21 August 2023 - The timing gap prompted concerns from public health experts, who fear that it would further complicate the ...
Posted by Michael Wonder on 25 Jul 2023
Paving the way towards coordinated clinical trials in public health emergencies in the EU
25 July 2023 - EMA has published a report from a workshop that collected insights and suggestions for possible EU level ...
Posted by Michael Wonder on 06 Jun 2023
EMA and ECDC statement on updating COVID-19 vaccines to target new SARS-CoV-2 virus variants
6 June 2023 - The European Centre for Disease Prevention and Control and the European Medicines Agency have issued a ...
Posted by Michael Wonder on 30 May 2023
ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older
30 May 2023 - ATAGI has made recommendations on the use of bivalent COVID-19 vaccines as a primary course. ...
Posted by Michael Wonder on 11 May 2023
EMA and European medicines regulatory network lift COVID-19 business continuity status
10 May 2023 - EMA and the European medicines regulatory network are lifting their respective COVID-19 business continuity measures after successfully ...
Posted by Michael Wonder on 09 May 2023
Statement from Emer Cooke on the end of the COVID-19 public health emergency
9 May 2023 - On Friday, the WHO Director General declared an end to the Public Health Emergency of International Concern ...
Posted by Michael Wonder on 10 Apr 2023
COVID-19 vaccine safety report (6 April 2023)
6 April 2023 - To 2 April 2023, more than 44 million doses of Comirnaty (Pfizer) mRNA vaccines have been administered in ...
Posted by Michael Wonder on 02 Apr 2023
Ensuring public trust in an empowered FDA
1 April 2023 - The FDA’s recent approval of lecanemab for Alzheimer’s disease has been clouded by controversy over other accelerated ...
Posted by Michael Wonder on 30 Mar 2023
WHO advisers to consider whether obesity medication should be added to Essential Medicines List
30 March 2023 - Advisers to the World Health Organization will consider next month whether to add liraglutide, the active ingredient ...
Posted by Michael Wonder on 30 Mar 2023
To deal with the next pandemic, the FDA needs an Office of Preparedness and Response
30 March 2023 - New evidence of the spillover of the avian flu virus, known as H5N1, to some mammals ...
Posted by Michael Wonder on 27 Mar 2023
COVID-19 vaccine safety report (23 March 2023)
23 March 2023 - To 19 March 2023, more than 44 million doses have been administered in Australia, as well ...
Posted by Michael Wonder on 11 Mar 2023
COVID-19 vaccine safety report (9 March 2023)
9 March 2023 - To 5 March 2023, over 44 million doses have been administered in Australia, as well as about ...
Posted by Michael Wonder on 01 Mar 2023
ATAGI recommendations on use of the Moderna bivalent (Original/Omicron BA.4/5) COVID-19 vaccine
28 February 2023 - Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Moderna bivalent ...